Outlook Therapeutics Inc (NASDAQ:OTLK)

1.39
Delayed Data
As of Aug 14
 +0.05 / +3.73%
Today’s Change
0.50
Today|||52-Week Range
2.14
+135.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$160.1M

Company Description

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.

Contact Information

Outlook Therapeutics, Inc.
4260 US Route 1
South Brunswick New Jersey 08852
P:(609) 619-3990
Investor Relations:

Employees

Shareholders

Individual stakeholders59.04%
Other institutional4.32%
Mutual fund holders0.54%

Top Executives

Lawrence A. KenyonPresident, CEO, CFO, Secretary & Treasurer
Terry DagnonChief Operating Officer
Jennifer M. KissnerSenior Vice President-Clinical Development
Jeff EvansonChief Commercial Officer